Supplemental material
Journal of Dermatological Treatment
Volume 34, 2023 - Issue 1
Research Article
Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan
Teppei Haginoa Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, JapanCorrespondence[email protected]
https://orcid.org/0000-0002-4183-9596View further author information
https://orcid.org/0000-0002-4183-9596View further author information, , , Hidehisa Saekib Department of Dermatology, Nippon Medical School, Tokyo, Japanhttps://orcid.org/0000-0002-1095-0355View further author information
https://orcid.org/0000-0002-1095-0355View further author information, & Naoko Kandaa Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japanhttps://orcid.org/0000-0003-4389-2312View further author information
https://orcid.org/0000-0003-4389-2312View further author information